WINNING THE BATTLE AGAINST ENDOTOXIC SEPTIC SHOCK

The first theranostic: EAA™ & Toraymyxin

Spectral welcomes the Mayo Clinic as its 19th site for the Tigris clinical trial

k

PRESS RELEASE

Spectral Medical Provides November Tigris Trial Update

79 patients enrolled TORONTO, Canada – December 4, 2023 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update for the month...

read more

Spectral Medical Announces CFO Departure

TORONTO, Canada – December 1, 2023 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that Blair McInnis has provided notice of...

read more

INVESTOR UPDATEs

Investor Update September 2023

EVENTS

Spectral to present at the virtual Sidoti Micro Cap Conference Thursday November 16th @ 9:15am ET

the balancing act on lifetime tv

Endotoxic Septic Shock  as featured on The Balancing Act on Lifetime TV.

Monday September 11 | 7:30am (ET/PT)

apac 2023

Dr. Kellum presenting on numerous topics at The 5th Asia Pacific Acute Kidney Injury & Continuous Renal Replacement Therapy Congress (APAC) including Septic Shock and the Tigris Trial

September 21 – 24, 2023, Daegu, Korea